Lobaplatin

(Synonyms: 络铂; D-19466)
目录号: PL01540 纯度: ≥98%
Lobaplatin (D-19466) 是铂 (II) 络合物的非对映混合物。Lobaplatin 将细胞周期阻滞在 G1 和 G2/M 期。Lobaplatin 通过增加 caspase和 Bax 的表达,降低 Bcl-2 的表达来诱导细胞凋亡 (apoptosis)。Lobaplatin 可用于癌症研究。
CAS No. :135558-11-1
商品编号 规格 价格 会员价 是否有货 数量
PL01540-1mg 1mg ¥2571.00 请登录
PL01540-5mg 5mg ¥7232.00 请登录
PL01540-10mg 10mg ¥12536.00 请登录
PL01540-50mg 50mg ¥36163.00 请登录
PL01540-100mg 100mg 询价 询价
PL01540-200mg 200mg 询价 询价
PL01540-10mM*1mLinWater 10mM*1mLinWater ¥7956.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Lobaplatin
中文别名
洛铂;4-甲基-2-吡唑啉-5-酮;乐巴铂;乐铂
英文名称
Lobaplatin
英文别名
Platinum,[rel-(1R,2R)-1,2-cyclobutanedimethanamine-kN,kN'][(2S)-2-(hydroxy-kO)propanoato(2-)-kO]-, (SP-4-3)- (9CI);Platinum, [rel-(1R,2R)-1,2-cyclobutanedimethanamine-.kappa.N,.kappa.N'][(2S)-2-(hydroxy-.kappa.O)propanoato(2-)-.kappa.O]-, (SP-4-3)- (9CI) (CA INDEX NAME);Platinum,[rel-(1R,2R)-1,2-cyclobutanedimethanamine-kN,kN'][(2S)-2-(hydroxy-kO)propanoato(2-)-k...;d19466;Lobaplatin (D-19466);lobaplatin
Cas No.
135558-11-1
分子式
C9H18N2O3Pt
分子量
395.31
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Lobaplatin (D-19466) 是铂 (II) 络合物的非对映混合物。Lobaplatin 将细胞周期阻滞在 G1 和 G2/M 期。Lobaplatin 通过增加 caspase和 Bax 的表达,降低 Bcl-2 的表达来诱导细胞凋亡 (apoptosis)。Lobaplatin 可用于癌症研究。
产品详情
Lobaplatin (D-19466) 是铂 (II) 络合物的非对映混合物。Lobaplatin 将细胞周期阻滞在 G1 和 G2/M 期。Lobaplatin 通过增加 caspase和 Bax 的表达,降低 Bcl-2 的表达来诱导细胞凋亡 (apoptosis)。Lobaplatin 可用于癌症研究。
生物活性
Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexe. Lobaplatin arrests cell cycle at G1 and G2/M phase. Lobaplatin induces apoptosis by increasing expressions of caspase and Bax, decreasing expression of Bcl-2. Lobaplatin can be used for research of cancer.
性状
Solid
体外研究(In Vitro)
Lobaplatin (D-19466, 0.25-32 μg/mL; 24-72 h) exhibits anti-proliferative activities against esophageal squamous cell carcinoma (ESCC) cell lines.
Lobaplatin (0-16 μg/mL; 48 h) induces esophageal squamous cell carcinoma (ESCC) apoptosis and modulates expression of apoptosis-related proteins.
Lobaplatin (1.45 μg/mL; 0-48 h; SMMC-7721 cells) arrests cell cycle progression at G1 and G2/M phases in a time-dependent manner.
Lobaplatin (1.45 μg/mL; 0-48 h; SMMC-7721 cells) inhibits the mRNA levels of cyclin B, CDK1, and CDC25C phosphatase, down-regulates Rb/E2F complexes and up-regulates of CDK inhibitors. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Lobaplatin (5 and 10 mg/kg; i.p.; once a week, for 3 weeks) suppresses tumor growth of esophageal squamous cell carcinoma (ESCC) xenograft. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Du L, et, al. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. Biomed Pharmacother. 2017 Nov;95:447-452.
[2]. Wu Q, et, al. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol. 2010 Oct 31;3:43.
溶解度数据
In Vitro: H2O : ≥ 50 mg/mL (125.84 mM; DMSO can inactivate Lobaplatins activity)
搜索质检报告(COA)
[1]. Du L, et, al. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. Biomed Pharmacother. 2017 Nov;95:447-452.
[2]. Wu Q, et, al. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol. 2010 Oct 31;3:43.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2